Anti-LRIG3 antibodies are used in the immunodetection of the protein leucine rich repeats and immunoglobulin like domains 3. In humans, the canonical protein has a reported length of 1119 amino acid residues and a mass of 123.4 kDa. Its subcellular localization is in the cytoplasmic vesicles and cell membrane. Up to 2 different isoforms have been reported for this protein. It is widely expressed across many tissue types. LRIG3 is believed to play a role in craniofacial and inner ear morphogenesis during embryonic development. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include leucine-rich repeats and immunoglobulin-like domains protein 3 and LIG-3. LRIG3 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of LRIG3 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.